Roberto A Novoa

Guest Editor for the following articles:

Mar
2019
Vol. 38. No. 1

Introduction, High-Risk Skin Cancer

Siegrid S Yu, MD

The majority of nonmelanoma skin cancers have excellent prognosis and are effectively treated with local, minimally invasive surgical or destructive techniques.

MORE
Mar
2019
Vol. 38. No. 1

Atypical Fibroxanthoma

Lance W Chapman, MD, MBA | Siegrid S Yu, MD | Sarah T Arron, MD, PhD

Atypical fibroxanthoma (AFX) is a dermal spindle-cell sarcoma that is considered a superficial and clinically benign presentation of pleomorphic dermal sarcoma, malignant fibrous histiocytoma, and undifferentiated pleomorphic sarcoma.

MORE
Mar
2019
Vol. 38. No. 1

Systemic therapy for advanced cutaneous squamous cell carcinoma

Kelly Fitzgerald, MD | Katy K Tsai, MD

The incidence of advanced cutaneous squamous cell carcinoma (cSCC) is increasing; of the 1.3 million nonmelanoma skin cancers that arise each year, approximately 20% are cSCC, and between 2-5% of these cases ultimately metastasize.

MORE